Figure 2
CD4+counts, CD4+Foxp3+, and CD4+Foxp3+ cell proportions in duodenal biopsies of patients with grade less than 2 or of 2 or more (first and second cohorts). (A) Absolute number of CD4+ cells per field in the first and second cohorts of duodenal biopsies. (B) Percentage of CD4+ cells expressing Foxp3 in the same cohorts. (C) Percentage of CD4+ cells expressing IL-17 in the same cohorts. An increased proportion of CD4+ cells expresses Foxp3 in duodenal biopsies of patients with grade 2 or more compared with patients with grade less than 2 in the 2 cohorts. A decreased proportion of CD4+ cells expresses IL-17 in duodenal biopsies of patients with grade 2 or more compared with patients with grade less than 2 in the 2 cohorts.

CD4+counts, CD4+Foxp3+, and CD4+Foxp3+ cell proportions in duodenal biopsies of patients with grade less than 2 or of 2 or more (first and second cohorts). (A) Absolute number of CD4+ cells per field in the first and second cohorts of duodenal biopsies. (B) Percentage of CD4+ cells expressing Foxp3 in the same cohorts. (C) Percentage of CD4+ cells expressing IL-17 in the same cohorts. An increased proportion of CD4+ cells expresses Foxp3 in duodenal biopsies of patients with grade 2 or more compared with patients with grade less than 2 in the 2 cohorts. A decreased proportion of CD4+ cells expresses IL-17 in duodenal biopsies of patients with grade 2 or more compared with patients with grade less than 2 in the 2 cohorts.

Close Modal

or Create an Account

Close Modal
Close Modal